Table of Content - Acne Treatment Market Report, Size | Industry Analysis, 2032

Research Methodology on Acne Treatment Market

Introduction

Acne is a skin disease caused by clogged pores and the overproduction of sebum, the oil which normalizes the functioning of skin cells. Acne treatment includes the use of medicinal products, topical gels and ointments, laser treatment, injections, and other methods to reduce the occurrence and severity of acne.

Acne is one of the most commonly encountered skin diseases in the world. It is estimated that almost 85 per cent of people between the ages of 12 and 24 have experienced acne. Factors such as increasing pollution levels, hormonal imbalances, unhygienic lifestyles, stress, and improper diets have been largely responsible for the spread of acne in the population. Additionally, the availability of better medical treatments and rising awareness about the prevention and treatment of acne have driven the growth of the global acne treatment market.

Research Methodology

This research is designed to provide an in-depth analysis of the global acne treatment market for the period of 2023-2030. It aims to identify key trends and developments that are influencing the growth of the market.

This research is based on a three-step approach. The first step is to collect and analyse primary and secondary information related to the global acne treatment market. Both qualitative and quantitative data were collected from the existing literature and studies, statistical databases, and published studies. The second step is to develop a market model that captures the current and future trends in the market. The model is based on a comprehensive assessment of the current market dynamics and trends. The last step is to analyse the model and draw conclusions and recommendations.

DATA SOURCES

The data sources used for this study include a range of primary and secondary sources. Primary sources such as interviews with market participants and surveys with industry experts were used to gain a better understanding of the market. Secondary sources such as publications, industry reports, the company’s annual reports and other related documents are used to collect data and analyze the market trends.

DATA COLLECTION

Primary data is collected through extensive interviews with industry stakeholders such as market vendors, product and technology providers, regulatory bodies and industry experts. Additionally, surveys and questionnaires were used to gain insight into the key market trends and the current market scenario.

Secondary data is collected from published industry reports, company databases and commercial databases such as Factiva and Bloomberg. Additionally, academic publications and research papers were used to gain an understanding of the current market trends and prospects.

DATA ANALYSIS

The data collected is analyzed using advanced quantitative and qualitative techniques such as descriptive and inferential statistics. The data is further analyzed using a variety of techniques such as SWOT and PESTLE analysis. These techniques are used to assess the current and potential market scenarios.

MARKET MODEL BUILDING

The market model was developed using qualitative and quantitative analyses. A ‘bottom-up’ approach is used to develop the market model. This approach is based on an analysis of the key drivers and current trends of the market. Combining the market data and analyses, the model was developed with foresight and accuracy to explain the current and future growth of the market. The model was further refined by including the points of view of stakeholders and industry experts.

FINDINGS

The findings of the research suggest that the global acne treatment market will experience steady growth between 2023 and 2030. The key factors driving the growth of the market are the growing prevalence of acne, increased awareness about the available treatments, and the availability of better medical treatments. Additionally, increasing pollution levels and unhygienic lifestyles have contributed to the prevalence of acne in the population, further driving the demand for acne treatments.

CONCLUSION

The findings of the research suggest that the global acne treatment market is expected to experience steady growth over the forecast period. The increasing prevalence of acne, growing awareness about the available treatments, and the availability of better medical treatments are the key drivers of the market. However, the high cost of acne treatments and the lack of regulatory oversight of the product may limit the growth of the market.

Leading companies partner with us for data-driven Insights

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY 18

1.1 OVERVIEW 18

1.1.1 MARKET SYNOPSIS 18

2 MARKET INTRODUCTION 19

2.1 SCOPE OF THE STUDY 19

2.2 RESEARCH OBJECTIVE 19

2.3 LIST OF ASSUMPTIONS & LIMITATIONS 19

3 RESEARCH METHODOLOGY 21

3.1 OVERVIEW 21

3.2 DATA MINING 21

3.3 SECONDARY RESEARCH 22

3.4 PRIMARY RESEARCH 23

3.4.1 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS 23

3.4.2 BREAKDOWN OF PRIMARY RESPONDENTS 24

3.5 FORECASTING TECHNIQUES 25

3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 25

3.6.1 BOTTOM-UP APPROACH 26

3.6.2 TOP-DOWN APPROACH 27

3.7 DATA TRIANGULATION 28

3.8 VALIDATION 28

4 MARKET DYNAMICS 29

4.1 OVERVIEW 29

4.2 DRIVERS 30

4.2.1 HIGH GLOBAL ACNE PREVALENCE 30

4.2.2 INCREASING SEDENTARY LIFESTYLE AND UNHEALTHY FOOD HABITS 30

4.2.3 HIGH INFLUENCE OF SOCIAL MEDIA AND BRAND ENDORSEMENTS 30

4.2.4 RISE IN THE DISPOSABLE INCOMES OF MIDDLE-CLASS PEOPLE 31

4.3 RESTRAINTS 32

4.3.1 SAFETY ISSUES REGARDING THE PRODUCTS 32

4.3.2 FAILURE OF PIVOTAL CLINICAL TRIALS FOR KEY CANDIDATES 32

4.4 OPPORTUNITIES 33

4.4.1 INCREASING AWARENESS ABOUT CURRENT AND UPCOMING ACNE TREATMENTS 33

4.5 TRENDS 33

4.5.1 ARTIFICIAL INTELLIGENCE ALGORITHM 33

4.5.2 PREFERENCE TOWARDS CLEAN SKINCARE ROUTINE 34

5 MARKET FACTOR ANALYSIS 35

5.1 VALUE CHAIN ANALYSIS 35

5.1.1 R&D AND DESIGNING 36

5.1.2 MANUFACTURING 36

5.1.3 DISTRIBUTION 36

5.1.4 MARKETING & SALES 36

5.2 PORTER’S FIVE FORCES MODEL 36

5.2.1 BARGAINING POWER OF SUPPLIERS 37

5.2.2 BARGAINING POWER OF BUYERS 37

5.2.3 THREAT OF NEW ENTRANTS 38

5.2.4 THREAT OF SUBSTITUTES 38

5.2.5 INTENSITY OF RIVALRY 38

5.3 IMPACT OF COVID-19 38

5.4 PESTEL ANALYSIS 40

6 GLOBAL ACNE TREATMENT MARKET, BY ACNE TYPE 41

6.1 OVERVIEW 41

6.2 MODERATE ACNE 42

6.3 MILD ACNE 43

6.4 MODERATE TO SEVERE ACNE 43

7 GLOBAL ACNE TREATMENT MARKET, BY TREATMENT 44

7.1 OVERVIEW 44

7.2 MEDICATION 45

7.3 THERAPEUTIC DEVICES 46

8 GLOBAL ACNE TREATMENT MARKET, BY DRUG TYPE 48

8.1 OVERVIEW 48

8.2 OTC 49

8.3 PRESCRIPTION 49

9 GLOBAL ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION 50

9.1 OVERVIEW 50

9.2 TOPICAL 51

9.3 ORAL 51

9.4 INJECTABLE 52

10 GLOBAL ACNE TREATMENT MARKET, BY END USER 53

10.1 OVERVIEW 53

10.2 HOSPITALS & CLINICS 54

10.3 SPECIALTY CENTERS 54

11 GLOBAL ACNE TREATMENT MARKET, BY REGION 55

11.1 OVERVIEW 55

11.2 AMERICAS 56

11.2.1 NORTH AMERICA 59

11.2.1.1 US 62

11.2.1.2 CANADA 65

11.2.2 LATIN AMERICA 67

11.3 EUROPE 70

11.3.1 WESTERN EUROPE 73

11.3.1.1 GERMANY 76

11.3.1.2 FRANCE 79

11.3.1.3 UK 80

11.3.1.4 ITALY 82

11.3.1.5 SPAIN 84

11.3.1.6 REST OF WESTERN EUROPE 86

11.3.2 EASTERN EUROPE 89

11.4 ASIA-PACIFIC 92

11.4.1 CHINA 95

11.4.2 JAPAN 98

11.4.3 INDIA 100

11.4.4 AUSTRALIA 102

11.4.5 SOUTH KOREA 104

11.4.6 REST OF ASIA-PACIFIC 106

11.5 MIDDLE EAST & AFRICA 109

11.5.1 MIDDLE EAST 112

11.5.2 AFRICA 115

12 COMPETITIVE LANDSCAPE 117

12.1 OVERVIEW 117

12.2 LEADING MARKET PLAYERS 117

12.3 GLOBAL ACNE TREATMENT MARKET SHARE ANALYSIS (2019) 118

12.4 COMPETITIVE BENCHMARKING 119

12.4.1 APPROVAL 120

12.4.2 PRODUCT LAUNCH 120

12.4.3 EXPANSION & ACQUISITION 121

12.4.4 AGREEMENT 121

12.5 LIST OF COMPANIES AND THEIR PRODUCTS FOR ACNE TREATMENT 122

13 COMPANY PROFILES 126

13.1 GLAXOSMITHKLINE PLC 126

13.1.1 COMPANY OVERVIEW 126

13.1.2 FINANCIAL OVERVIEW 127

13.1.3 PRODUCTS/SERVICES OFFERED 127

13.1.4 KEY DEVELOPMENTS 128

13.1.5 SWOT ANALYSIS 128

13.1.6 KEY STRATEGIES 128

13.2 ALMIRALL, S.A. 129

13.2.1 COMPANY OVERVIEW 129

13.2.2 FINANCIAL OVERVIEW 129

13.2.3 PRODUCTS/SERVICES OFFERED 130

13.2.4 ALMIRALL, S.A: KEY DEVELOPMENTS 130

13.2.5 SWOT ANALYSIS 131

13.2.6 KEY STRATEGIES 131

13.3 GALDERMA LABORATORIES, L.P. 132

13.3.1 COMPANY OVERVIEW 132

13.3.2 FINANCIAL OVERVIEW 132

13.3.3 PRODUCTS/SERVICES OFFERED 132

13.3.4 KEY DEVELOPMENTS 133

13.3.5 SWOT ANALYSIS 133

13.3.6 KEY STRATEGIES 133

13.4 F. HOFFMAN LA ROCHE LTD 134

13.4.1 COMPANY OVERVIEW 134

13.4.2 FINANCIAL OVERVIEW 135

13.4.3 PRODUCTS/SERVICES OFFERED 135

13.4.4 KEY DEVELOPMENTS 135

13.4.5 SWOT ANALYSIS 136

13.4.6 KEY STRATEGIES 136

13.5 BAUSCH HEALTH COMPANIES INC. 137

13.5.1 COMPANY OVERVIEW 137

13.5.2 FINANCIAL OVERVIEW 137

13.5.3 PRODUCTS/SERVICES OFFERED 138

13.5.4 KEY DEVELOPMENTS 138

13.5.5 SWOT ANALYSIS 139

13.5.6 KEY STRATEGIES 139

13.6 LEO PHARMA A/S 140

13.6.1 COMPANY OVERVIEW 140

13.6.2 FINANCIAL OVERVIEW 140

13.6.3 PRODUCTS/SERVICES OFFERED 141

13.6.4 KEY DEVELOPMENTS 141

13.6.5 SWOT ANALYSIS 141

13.6.6 KEY STRATEGIES 142

13.7 JOHNSON & JOHNSON SERVICES INC. 143

13.7.1 COMPANY OVERVIEW 143

13.7.2 FINANCIAL OVERVIEW 143

13.7.3 PRODUCTS/SERVICES OFFERED 144

13.7.4 KEY DEVELOPMENTS 144

13.7.5 SWOT ANALYSIS 144

13.7.6 KEY STRATEGIES 145

13.8 TEVA PHARMACEUTICAL INDUSTRIES LTD 146

13.8.1 COMPANY OVERVIEW 146

13.8.2 FINANCIAL OVERVIEW 146

13.8.3 PRODUCTS/SERVICES OFFERED 147

13.8.4 KEY DEVELOPMENTS 147

13.8.5 SWOT ANALYSIS 147

13.8.6 KEY STRATEGIES 148

13.9 CANDELA CORPORATION 149

13.9.1 COMPANY OVERVIEW 149

13.9.2 FINANCIAL OVERVIEW 149

13.9.3 PRODUCTS/SERVICES OFFERED 149

13.9.4 KEY DEVELOPMENTS 149

13.9.5 SWOT ANALYSIS 150

13.9.6 KEY STRATEGIES 150

13.10 VYNE THERAPEUTICS INC. 151

13.10.1 COMPANY OVERVIEW 151

13.10.2 FINANCIAL OVERVIEW 151

13.10.3 PRODUCTS/SERVICES OFFERED 151

13.10.4 KEY DEVELOPMENTS 152

13.10.5 SWOT ANALYSIS 152

13.10.6 KEY STRATEGIES 152

14 APPENDIX 153

14.1 REFERENCES 153

14.2 RELATED REPORTS 153

LIST OF TABLES

TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS 19

TABLE 2 NUMBER OF PRIMARY RESPONDENTS BY REGION 24

TABLE 3 GLOBAL ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 41

TABLE 4 GLOBAL ACNE TREATMENT MARKET, FOR MODERATE ACNE, BY REGION, 2017-2027 (USD MILLION) 42

TABLE 5 GLOBAL ACNE TREATMENT MARKET, FOR MILD ACNE, BY REGION, 2017-2027 (USD MILLION) 43

TABLE 6 GLOBAL ACNE TREATMENT MARKET, FOR MODERATE TO SEVERE ACNE, BY REGION, 2017-2027 (USD MILLION) 43

TABLE 7 GLOBAL ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 44

TABLE 8 GLOBAL ACNE TREATMENT MARKET, FOR MEDICATION, BY REGION, 2017-2027 (USD MILLION) 45

TABLE 9 GLOBAL ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 46

TABLE 10 GLOBAL ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY REGION, 2017-2027 (USD MILLION) 46

TABLE 11 GLOBAL ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 47

TABLE 12 GLOBAL ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 48

TABLE 13 GLOBAL ACNE TREATMENT MARKET, FOR OTC, BY REGION, 2017-2027 (USD MILLION) 49

TABLE 14 GLOBAL ACNE TREATMENT MARKET, FOR PRESCRIPTION, BY REGION, 2017-2027 (USD MILLION) 49

TABLE 15 GLOBAL ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 50

TABLE 16 GLOBAL ACNE TREATMENT MARKET, FOR TOPICAL, BY REGION, 2017-2027 (USD MILLION) 51

TABLE 17 GLOBAL ACNE TREATMENT MARKET, FOR ORAL, BY REGION, 2017-2027 (USD MILLION) 52

TABLE 18 GLOBAL ACNE TREATMENT MARKET, FOR INJECTABLE, BY REGION, 2017-2027 (USD MILLION) 52

TABLE 19 GLOBAL ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 53

TABLE 20 GLOBAL ACNE TREATMENT MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2017-2027 (USD MILLION) 54

TABLE 21 GLOBAL ACNE TREATMENT MARKET, FOR SPECIALTY CENTERS, BY REGION, 2017-2027 (USD MILLION) 54

TABLE 22 GLOBAL ACNE TREATMENT MARKET, BY REGION, 2017-2027 (USD MILLION) 55

TABLE 23 AMERICAS: ACNE TREATMENT MARKET, BY REGION, 2017-2027 (USD MILLION) 56

TABLE 24 AMERICAS: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 57

TABLE 25 AMERICAS: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 57

TABLE 26 AMERICAS: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 57

TABLE 27 AMERICAS: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 58

TABLE 28 AMERICAS: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 58

TABLE 29 AMERICAS: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 58

TABLE 30 AMERICAS: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 59

TABLE 31 NORTH AMERICA: ACNE TREATMENT MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 59

TABLE 32 NORTH AMERICA: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 60

TABLE 33 NORTH AMERICA: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 60

TABLE 34 NORTH AMERICA: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 60

TABLE 35 NORTH AMERICA: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 61

TABLE 36 NORTH AMERICA: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 61

TABLE 37 NORTH AMERICA: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 61

TABLE 38 NORTH AMERICA: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 62

TABLE 39 US: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 62

TABLE 40 US: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 62

TABLE 41 US: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 63

TABLE 42 US: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 63

TABLE 43 US: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 63

TABLE 44 US: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 64

TABLE 45 US: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 64

TABLE 46 CANADA: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 65

TABLE 47 CANADA: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 65

TABLE 48 CANADA: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 65

TABLE 49 CANADA: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 66

TABLE 50 CANADA: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 66

TABLE 51 CANADA: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 66

TABLE 52 CANADA: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 66

TABLE 53 LATIN AMERICA: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 67

TABLE 54 LATIN AMERICA: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 67

TABLE 55 LATIN AMERICA: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 67

TABLE 56 LATIN AMERICA: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 68

TABLE 57 LATIN AMERICA: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 68

TABLE 58 LATIN AMERICA: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 68

TABLE 59 LATIN AMERICA: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 69

TABLE 60 EUROPE: ACNE TREATMENT MARKET, BY REGION, 2017-2027 (USD MILLION) 70

TABLE 61 EUROPE: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 71

TABLE 62 EUROPE: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 71

TABLE 63 EUROPE: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 71

TABLE 64 EUROPE: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 72

TABLE 65 EUROPE: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 72

TABLE 66 EUROPE: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 72

TABLE 67 EUROPE: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 72

TABLE 68 WESTERN EUROPE: ACNE TREATMENT MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 73

TABLE 69 WESTERN EUROPE: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 74

TABLE 70 WESTERN EUROPE: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 74

TABLE 71 WESTERN EUROPE: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 74

TABLE 72 WESTERN EUROPE: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 75

TABLE 73 WESTERN EUROPE: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 75

TABLE 74 WESTERN EUROPE: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 75

TABLE 75 WESTERN EUROPE: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 76

TABLE 76 GERMANY: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 76

TABLE 77 GERMANY: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 76

TABLE 78 GERMANY: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 77

TABLE 79 GERMANY: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 77

TABLE 80 GERMANY: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 77

TABLE 81 GERMANY: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 78

TABLE 82 GERMANY: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 78

TABLE 83 FRANCE: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 79

TABLE 84 FRANCE: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 79

TABLE 85 FRANCE: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 79

TABLE 86 FRANCE: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 80

TABLE 87 FRANCE: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 80

TABLE 88 FRANCE: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 80

TABLE 89 FRANCE: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 80

TABLE 90 UK: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 81

TABLE 91 UK: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 81

TABLE 92 UK: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 81

TABLE 93 UK: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 82

TABLE 94 UK: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 82

TABLE 95 UK: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 82

TABLE 96 UK: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 82

TABLE 97 ITALY: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 83

TABLE 98 ITALY: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 83

TABLE 99 ITALY: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 83

TABLE 100 ITALY: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 84

TABLE 101 ITALY: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 84

TABLE 102 ITALY: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 84

TABLE 103 ITALY: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 84

TABLE 104 SPAIN: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 85

TABLE 105 SPAIN: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 85

TABLE 106 SPAIN: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 85

TABLE 107 SPAIN: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 86

TABLE 108 SPAIN: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 86

TABLE 109 SPAIN: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 86

TABLE 110 SPAIN: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 86

TABLE 111 REST OF WESTERN EUROPE: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 87

TABLE 112 REST OF WESTERN EUROPE: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 87

TABLE 113 REST OF WESTERN EUROPE: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 87

TABLE 114 REST OF WESTERN EUROPE: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 88

TABLE 115 REST OF WESTERN EUROPE: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 88

TABLE 116 REST OF WESTERN EUROPE: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 88

TABLE 117 REST OF WESTERN EUROPE: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 89

TABLE 118 EASTERN EUROPE: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 89

TABLE 119 EASTERN EUROPE: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 89

TABLE 120 EASTERN EUROPE: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 90

TABLE 121 EASTERN EUROPE: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 90

TABLE 122 EASTERN EUROPE: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 90

TABLE 123 EASTERN EUROPE: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 91

TABLE 124 EASTERN EUROPE: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 91

TABLE 125 ASIA-PACIFIC: ACNE TREATMENT MARKET, BY COUNTRY, 2017-2027 (USD MILLION) 92

TABLE 126 ASIA-PACIFIC: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 93

TABLE 127 ASIA-PACIFIC: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 93

TABLE 128 ASIA-PACIFIC: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 93

TABLE 129 ASIA-PACIFIC: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 94

TABLE 130 ASIA-PACIFIC: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 94

TABLE 131 ASIA-PACIFIC: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 94

TABLE 132 ASIA-PACIFIC: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 95

TABLE 133 CHINA: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 95

TABLE 134 CHINA: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 95

TABLE 135 CHINA: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 96

TABLE 136 CHINA: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 96

TABLE 137 CHINA: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 96

TABLE 138 CHINA: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 97

TABLE 139 CHINA: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 97

TABLE 140 JAPAN: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 98

TABLE 141 JAPAN: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 98

TABLE 142 JAPAN: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 98

TABLE 143 JAPAN: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 99

TABLE 144 JAPAN: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 99

TABLE 145 JAPAN: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 99

TABLE 146 JAPAN: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 99

TABLE 147 INDIA: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 100

TABLE 148 INDIA: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 100

TABLE 149 INDIA: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 100

TABLE 150 INDIA: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 101

TABLE 151 INDIA: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 101

TABLE 152 INDIA: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 101

TABLE 153 INDIA: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 101

TABLE 154 AUSTRALIA: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 102

TABLE 155 AUSTRALIA: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 102

TABLE 156 AUSTRALIA: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 102

TABLE 157 AUSTRALIA: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 103

TABLE 158 AUSTRALIA: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 103

TABLE 159 AUSTRALIA: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 103

TABLE 160 AUSTRALIA: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 104

TABLE 161 SOUTH KOREA: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 104

TABLE 162 SOUTH KOREA: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 104

TABLE 163 SOUTH KOREA: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 105

TABLE 164 SOUTH KOREA: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 105

TABLE 165 SOUTH KOREA: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 105

TABLE 166 SOUTH KOREA: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 106

TABLE 167 SOUTH KOREA: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 106

TABLE 168 REST OF ASIA-PACIFIC: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 106

TABLE 169 REST OF ASIA-PACIFIC: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 107

TABLE 170 REST OF ASIA-PACIFIC: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 107

TABLE 171 REST OF ASIA-PACIFIC: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 107

TABLE 172 REST OF ASIA-PACIFIC: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 108

TABLE 173 REST OF ASIA-PACIFIC: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 108

TABLE 174 REST OF ASIA-PACIFIC: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 108

TABLE 175 MIDDLE EAST & AFRICA: ACNE TREATMENT MARKET, BY REGION, 2017-2027 (USD MILLION) 109

TABLE 176 MIDDLE EAST & AFRICA: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 110

TABLE 177 MIDDLE EAST & AFRICA: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 110

TABLE 178 MIDDLE EAST & AFRICA: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 110

TABLE 179 MIDDLE EAST & AFRICA: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 111

TABLE 180 MIDDLE EAST & AFRICA: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 111

TABLE 181 MIDDLE EAST & AFRICA: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 111

TABLE 182 MIDDLE EAST & AFRICA: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 112

TABLE 183 MIDDLE EAST: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 112

TABLE 184 MIDDLE EAST: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 112

TABLE 185 MIDDLE EAST: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 113

TABLE 186 MIDDLE EAST: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 113

TABLE 187 MIDDLE EAST: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 113

TABLE 188 MIDDLE EAST: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 114

TABLE 189 MIDDLE EAST: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 114

TABLE 190 AFRICA: ACNE TREATMENT MARKET, BY ACNE TYPE, 2017-2027 (USD MILLION) 115

TABLE 191 AFRICA: ACNE TREATMENT MARKET, BY TREATMENT, 2017-2027 (USD MILLION) 115

TABLE 192 AFRICA: ACNE TREATMENT MARKET, FOR MEDICATION, BY TYPE, 2017-2027 (USD MILLION) 115

TABLE 193 AFRICA: ACNE TREATMENT MARKET, FOR THERAPEUTIC DEVICES, BY TYPE, 2017-2027 (USD MILLION) 116

TABLE 194 AFRICA: ACNE TREATMENT MARKET, BY DRUG TYPE, 2017-2027 (USD MILLION) 116

TABLE 195 AFRICA: ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2017-2027 (USD MILLION) 116

TABLE 196 AFRICA: ACNE TREATMENT MARKET, BY END USER, 2017-2027 (USD MILLION) 116

TABLE 197 APPROVAL 120

TABLE 198 PRODUCT LAUNCH 120

TABLE 199 EXPANSION & ACQUISITION 121

TABLE 200 AGREEMENT & MERGER 121

TABLE 201 LIST OF COMPANIES AND THEIR PRODUCTS 122

TABLE 202 GLAXOSMITHKLINE PLC: PRODUCTS/SERVICES OFFERED 127

TABLE 203 ALMIRALL, S.A: PRODUCTS/SERVICES OFFERED 130

TABLE 204 ALMIRALL, S.A: KEY DEVELOPMENTS 130

TABLE 205 GALDERMA LABORATORIES, LP: PRODUCTS/SERVICES OFFERED 132

TABLE 206 F. HOFFMAN LA ROCHE LTD: PRODUCTS/SERVICES OFFERED 135

TABLE 207 BAUSCH HEALTH COMPANIES INC.: PRODUCTS/SERVICES OFFERED 138

TABLE 208 BAUSCH HEALTH COMPANIES INC.: KEY DEVELOPMENTS 138

TABLE 209 LEO PHARMA A/S: PRODUCTS/SERVICES OFFERED 141

TABLE 210 LEO PHARMA A/S: KEY DEVELOPMENTS 141

TABLE 211 JOHNSON & JOHNSON SERVICES INC.: PRODUCTS/SERVICES OFFERED 144

TABLE 212 JOHNSON & JOHNSON SERVICES INC.: KEY DEVELOPMENTS 144

TABLE 213 TEVA PHARMACEUTICAL INDUSTRIES LTD: PRODUCTS/SERVICES OFFERED 147

TABLE 214 TEVA PHARMACEUTICAL INDUSTRIES LTD: KEY DEVELOPMENTS 147

TABLE 215 CANDELA CORPORATION: PRODUCTS/SERVICES OFFERED 149

TABLE 216 CANDELA CORPORATION: KEY DEVELOPMENTS 149

TABLE 217 VYNE THERAPEUTICS INC.: PRODUCTS/SERVICES OFFERED 151

TABLE 218 VYNE THERAPEUTICS INC.: KEY DEVELOPMENTS 152

LIST OF FIGURES

FIGURE 1 GLOBAL ACNE TREATMENT MARKET STRUCTURE 20

FIGURE 2 BOTTOM-UP AND TOP-DOWN APPROACHES 26

FIGURE 3 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL ACNE TREATMENT MARKET 29

FIGURE 4 DRIVER IMPACT ANALYSIS 31

FIGURE 5 RESTRAINT IMPACT ANALYSIS 32

FIGURE 6 VALUE CHAIN: GLOBAL ACNE TREATMENT MARKET 35

FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: GLOBAL ACNE TREATMENT MARKET 37

FIGURE 8 CONSUMER PURCHASE PREFERENCE DURING COVID-19 39

FIGURE 9 PESTEL ANALYSIS 40

FIGURE 10 GLOBAL ACNE TREATMENT MARKET, BY ACNE TYPE, 2019 AND 2027 (USD MILLION) 41

FIGURE 11 GLOBAL ACNE TREATMENT MARKET, BY TREATMENT, 2019 AND 2027 (USD MILLION) 44

FIGURE 12 GLOBAL ACNE TREATMENT MARKET, BY DRUG TYPE, 2019 AND 2027 (USD MILLION) 48

FIGURE 13 GLOBAL ACNE TREATMENT MARKET, BY ROUTE OF ADMINISTRATION, 2019 AND 2027 (USD MILLION) 50

FIGURE 14 GLOBAL ACNE TREATMENT MARKET, BY END USER, 2019 AND 2027 (USD MILLION) 53

FIGURE 15 GLOBAL ACNE TREATMENT MARKET, BY REGION, 2019 AND 2027 (USD MILLION) 55

FIGURE 16 AMERICAS: ACNE TREATMENT MARKET, BY REGION, 2019 (%) 56

FIGURE 17 NORTH AMERICA: ACNE TREATMENT MARKET, BY COUNTRY, 2019 (%) 59

FIGURE 18 EUROPE: ACNE TREATMENT MARKET, BY REGION, 2019 (%) 70

FIGURE 19 WESTERN EUROPE: ACNE TREATMENT MARKET, BY COUNTRY, 2019 (%) 73

FIGURE 20 ASIA-PACIFIC: ACNE TREATMENT MARKET, BY COUNTRY, 2019 (%) 92

FIGURE 21 MIDDLE EAST & AFRICA: ACNE TREATMENT MARKET, BY REGION, 2019 (%) 109

FIGURE 22 GLOBAL ACNE TREATMENT MARKET SHARE ANALYSIS (2019) 118

FIGURE 23 BENCHMARKING OF MAJOR COMPETITORS 119

FIGURE 24 GLAXOSMITHKLINE PLC: FINANCIAL OVERVIEW SNAPSHOT 127

FIGURE 25 GLAXOSMITHKLINE PLC: SWOT ANALYSIS 128

FIGURE 26 ALMIRALL, S.A: FINANCIAL OVERVIEW SNAPSHOT 129

FIGURE 27 ALMIRALL, S.A: SWOT ANALYSIS 131

FIGURE 28 GALDERMA LABORATORIES, LP: KEY DEVELOPMENTS 133

FIGURE 29 GALDERMA LABORATORIES, L.P.: SWOT ANALYSIS 133

FIGURE 30 F. HOFFMAN LA ROCHE LTD: FINANCIAL OVERVIEW SNAPSHOT 135

FIGURE 31 F. HOFFMAN LA ROCHE LTD: SWOT ANALYSIS 136

FIGURE 32 BAUSCH HEALTH COMPANIES INC.: FINANCIAL OVERVIEW SNAPSHOT 137

FIGURE 33 BAUSCH HEALTH COMPANIES INC.: SWOT ANALYSIS 139

FIGURE 34 LEO PHARMA A/S: FINANCIAL OVERVIEW SNAPSHOT 140

FIGURE 35 LEO PHARMA A/S: SWOT ANALYSIS 141

FIGURE 36 JOHNSON & JOHNSON SERVICES INC.: FINANCIAL OVERVIEW SNAPSHOT 143

FIGURE 37 JOHNSON & JOHNSON SERVICES INC.: SWOT ANALYSIS 144

FIGURE 38 TEVA PHARMACEUTICAL INDUSTRIES LTD: FINANCIAL OVERVIEW SNAPSHOT 146

FIGURE 39 TEVA PHARMACEUTICAL INDUSTRIES LTD: SWOT ANALYSIS 147

FIGURE 40 CANDELA CORPORATION: SWOT ANALYSIS 150

FIGURE 41 VYNE THERAPEUTICS INC.: FINANCIAL OVERVIEW SNAPSHOT 151

FIGURE 42 VYNE THERAPEUTICS INC.: SWOT ANALYSIS 152

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions

Certified Global Research Member

Key Questions Answered

Why Choose Market Research Future?

Research Methodology on Acne Treatment Market

Leading companies partner with us for data-driven Insights

Tailored for You